BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 31582210)

  • 1. Chemical toolbox to interrogate Heparanase-1 activity.
    Rabinowitz ZM; Somers J; Wang Z; Cui L
    Curr Opin Chem Biol; 2024 Jun; 80():102452. PubMed ID: 38555836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Heparanase and Syndecan-1 in HSV-1 Release from Infected Cells.
    Sharma P; Kapoor D; Shukla D
    Viruses; 2022 Sep; 14(10):. PubMed ID: 36298711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of human heparanase reveals insights into substrate recognition.
    Wu L; Viola CM; Brzozowski AM; Davies GJ
    Nat Struct Mol Biol; 2015 Dec; 22(12):1016-22. PubMed ID: 26575439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparanase, cell signaling, and viral infections.
    Koganti R; Suryawanshi R; Shukla D
    Cell Mol Life Sci; 2020 Dec; 77(24):5059-5077. PubMed ID: 32462405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developing a solid-phase method for the enzymatic synthesis of heparan sulfate and chondroitin sulfate backbones.
    Stancanelli E; Liu W; Su G; Padagala V; Liu J
    Glycobiology; 2024 Mar; 34(2):. PubMed ID: 37995272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfation of Heparan and Chondroitin Sulfate Ligands Enables Cell-Specific Homing of Nanoprobes.
    Mardhekar S; Subramani B; Samudra P; Srikanth P; Mahida V; Ravindra Bhoge P; Toraskar S; Abraham NM; Kikkeri R
    Chemistry; 2023 Feb; 29(7):e202202622. PubMed ID: 36325647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparanase enzyme in chronic inflammatory bowel disease and colon cancer.
    Hermano E; Lerner I; Elkin M
    Cell Mol Life Sci; 2012 Aug; 69(15):2501-13. PubMed ID: 22331282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondroitin sulfate is indispensable for pluripotency and differentiation of mouse embryonic stem cells.
    Izumikawa T; Sato B; Kitagawa H
    Sci Rep; 2014 Jan; 4():3701. PubMed ID: 24424429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of heparanase on renal fibrosis.
    Masola V; Zaza G; Onisto M; Lupo A; Gambaro G
    J Transl Med; 2015 Jun; 13():181. PubMed ID: 26040666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-O-Substituted Glucuronic Cyclophellitols are Selective Mechanism-Based Heparanase Inhibitors.
    Borlandelli V; Armstrong Z; Nin-Hill A; Codée JDC; Raich L; Artola M; Rovira C; Davies GJ; Overkleeft HS
    ChemMedChem; 2023 Feb; 18(4):e202200580. PubMed ID: 36533564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondroitin sulfate-modified antiangiogenic peptide conjugate induces cell apoptosis via the mitochondria-mediated pathway to perform antitumor activity.
    Li Y; Fu J; Hou H; Tang W; Liu Z; Gao D; Zhao F; Gao X; Sun F; Tan H
    Int J Biol Macromol; 2024 Mar; 262(Pt 1):129671. PubMed ID: 38423906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phylogenetic analysis of Heparanase (HPSE) gene.
    Shaik AP; Alsaeed AH; Sultana A
    Bioinformation; 2012; 8(9):415-9. PubMed ID: 22715311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic platinum through glycan targeting.
    Peterson EJ; Daniel AG; Katner SJ; Bohlmann L; Chang CW; Bezos A; Parish CR; von Itzstein M; Berners-Price SJ; Farrell NP
    Chem Sci; 2017 Jan; 8(1):241-252. PubMed ID: 28451171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms.
    Molderings GJ; Afrin LB
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2881-2891. PubMed ID: 37243761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfated Hyaluronan Binds to Heparanase and Blocks Its Enzymatic and Cellular Actions in Carcinoma Cells.
    Shi J; Kanoya R; Tani Y; Ishikawa S; Maeda R; Suzuki S; Kawanami F; Miyagawa N; Takahashi K; Oku T; Yamamoto A; Fukuzawa K; Nakajima M; Irimura T; Higashi N
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Characterization and Heparanase Inhibitory Activity of Fucosylated Glycosaminoglycan from
    Shi X; Guan R; Zhou L; Zuo Z; Tao X; Wang P; Zhou Y; Yin R; Zhao L; Gao N; Zhao J
    Mar Drugs; 2021 Mar; 19(3):. PubMed ID: 33803892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chondroitin sulfate E blocks enzymatic action of heparanase and heparanase-induced cellular responses.
    Higashi N; Maeda R; Sesoko N; Isono M; Ishikawa S; Tani Y; Takahashi K; Oku T; Higashi K; Onishi S; Nakajima M; Irimura T
    Biochem Biophys Res Commun; 2019 Nov; 520(1):152-158. PubMed ID: 31582210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix.
    Bashkin P; Razin E; Eldor A; Vlodavsky I
    Blood; 1990 Jun; 75(11):2204-12. PubMed ID: 1693299
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.